Image-Guided Adaptive Therapy for the Treatment of Lung Cancer

Slides:



Advertisements
Similar presentations
A phase I dose escalating study of intensity modulated radiation therapy (IMRT) for the treatment of glioblastoma multiforme (GBM) ( #1008) V. Stieber.
Advertisements

CTOS, Boca Raton, 2005 A Radiation Treatment Planning Comparison for Lower Extremity Soft Tissue Sarcoma: Can the Future Surgical Wound Be Spared? Anthony.
Multidisciplinary approaches on chest tumors Radiation Oncology Case Reports.
Image Guided Radiation Therapy (IGRT) in prostate cancer MªCarmen Pujades Hospital Universitario La Fe Fundación Instituto Valenciano de Oncología (FIVO)
IMRT vs. BRACHYTHERAPY FOR SOFT TISSUE SARCOMA. EXTERNAL RT IN STS NCI Trial (Yang JC et al, JCO 1998) Extremity / Superficial Trunk STS (n=141) LSS Alone.
Impact of imaging on newer radiation techniques in Gynaecological cancer.
Stereotactic Body Radiation Therapy (SBRT): The optimal indication for operable tumors in inoperable patients D.Katsochi 1, S.Kosmidis 1, A.Fotopoulou.
The Health Roundtable 1-1b_HRT1215-Session_HEGI_JOHNSON_WESTMEAD_NSW Volumetric Modulated Arc Therapy for Stereotactic Body Radiotherapy in Early Lung.
Radiotherapy Planning for Esophageal Cancers Parag Sanghvi, MD, MSPH 9/12/07 Esophageal Cancer Tumor Board Part 1.
Prof Ramesh S Bilimagga President AROI Group Medical Director - HCG.
ICRU 50 & ICRU 62 Paweł Kukołowicz Holycross Cancer Centre
Treatment Guidelines for Pre-operative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel EH Baldini,
Prediction of Regional Tumor Spread Using Markov Models Megan S. Blackburn Monday, April 14, 2008.
What are V20 and V5 and how do we reduce dose to normal lung?
H Ariyaratne1,2, H Chesham2, J Pettingell2, K Sikora2, R Alonzi1,2
Region of Interest Analysis as a Tool for Exploring Adaptive IMRT Strategy for Cervix Cancer Patients Young-Bin Cho 1,2, Valerie Kelly 1, Karen Lim 1,2,
Phase II Trial of Continuous Course Re- irradiation Concurrent with Weekly Cisplatinum and Cetuximab for Recurrent Squamous Cell Carcinoma of The Head.
HEAPHY 1 & 2 CASE RACE 2 – RT Tony FALLON Sat 31 st Aug 2013 Session 3 / CR2-2 13:41 – 13:45 CANTERBURY / WESTLAND ABSTRACT This case race presents the.
Learn More At: CyberKnife Radiosurgery in the Treatment of Early and Advanced (Oligo-Metastases) Breast Cancer Sandra Vermeulen,
Clinical decisions in the optimization process I. Emphasis on tumor control issues Avi Eisbruch University of Michigan.
Workshop on Advanced Technologies in Radiation Oncology Kian Ang.
Somvilai Mayurasakorn, MD. Division of Therapeutic Radiology and Oncology, Faculty of Medicine, Chiang Mai University Somvilai Mayurasakorn, MD. Division.
Purpose and Objectives: To investigate
Assessment of radiotherapy set-up error for limb sarcoma using electronic portal imaging (EPI) Wendy Ella, Eleanor Gill, Anna Cassoni, Beatrice Seddon.
Introduction to Radiation Therapy
Taipei VGH Practice Guidelines: Oncology Guidelines Index Cancer of Lung Version Table of Content StagingStaging, ManuscriptManuscript Taipei Veterans.
Taipei VGH Practice Guidelines: Oncology Guidelines Index Cancer of Oral Cavity Version Table of Content StagingStaging, Manuscript Taipei Veterans.
Reducing excess imaging dose to cancer patients receiving radiotherapy Adam Schwertner, Justin Guan, Xiaofei Ying, Darrin Pelland, Ann Morris, Ryan Flynn.
SARC018: A SARC PILOT MULTICENTER STUDY OF PREOPERATIVE RADIATION AND SURGERY IN PATIENTS WITH HIGH- RISK DESMOID TUMORS Robert S. Benjamin, M.D.
 Multidisciplinary Effort › Surgery › Radiation › Systemic Rx (chemo, “drugs”)
Patient and Tumour Characteristics Median age 60 years (26-92) Karnofsky Status:median 90 (50-100) Histology:SCC: n=120 (83%) Tumor size: ≥ 5 cm: n=78.
Taipei Veterans General Hospital Practices Guidelines Radiation Oncology Lung Cancer Version
Taipei Veterans General Hospital Practices Guidelines Oncology Rectal Cancer Version
Taipei Veterans General Hospital Practices Guidelines Oncology Oral Cavity Cancer Version
Lung SBRT Implementation at the Regional Cancer Centre
Dr. Malhar Patel DNB (Radiation Oncology)
Modern Radiation Oncology
Management of independent motion between multiple targets in lung cancer radiation therapy  Feng Liu, PhD, An Tai, PhD, Ergun Ahunbay, PhD, Elizabeth.
Neuroaxis Radiation for pediatric tumors (Medulloblastoma and Atypical teratoid/rhabdoid tumor) with VMAT (volumetric modulated arc therapy) and IMRT (intensity.
Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer  Shervin M. Shirvani, MD, Ann.
Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group  Joachim Yahalom,
The use of 4DCT images to optimize the Internal Target Volume in Radiotherapy  Nikos Giakoumakis, Brian Winey, Joseph Killoran, Tania Lingos, Laurence.
Feasibility of hippocampal sparing radiation therapy for glioblastoma using helical Tomotherapy Dr Kamalram THIPPU JAYAPRAKASH1,2,3, Dr Raj JENA1,4 and.
Marked Tumor Response and Fatal Hemoptysis During Radiation for Lung Cancer in a Human Immunodeficiency Virus-Positive Patient Taking Nelfinavir  Christopher.
Image–Guided Radiation Therapy for Non–small Cell Lung Cancer
IMRT delivery of preoperative, high dose radiotherapy to a large volume, with Simultaneous Integrated Boost (SIB) in retroperitoneal sarcomas: The Ottawa.
Comparison of carina- versus bony anatomy-based registration for setup verification in esophageal cancer image-guided radiotherapy Melanie Machiels* 1,
RTOG 0126 A Phase III Randomized Study of High Dose 3D-CRT/IMRT versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer Bijoy.
Fig. 4. Percentage of passing rate between clinical and 544 plans.
Reducing Treatment Time and MUs by using Dynamic Conformal Arc Therapy for SBRT Breath-Hold Patients Timothy Miller, Sebastian Nunez Albermann, Besil Raju,
Neuroaxis Radiation for pediatric tumors (Medulloblastoma and Atypical teratoid/rhabdoid tumor) with VMAT (volumetric modulated arc therapy) and IMRT (intensity.
Insert tables Insert graphs Insert figure
Modern Treatment Planning
Median Volume (cc) of GTV Receiving Dose
Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer  Shervin M. Shirvani, MD, Ann.
Volumetric Modulated Arc Therapy (VMAT) versus Intensity Modulated Radiation Therapy (IMRT) for Anal Carcinoma Heather Ortega, BSRT(T), CMD, Kerry Hibbitts,
L. A. den Otter. , R. M. Anakotta. , M. Dieters. , C. T. Muijs. , S
Improved outcome of treating locally advanced lung cancer with the use of Lattice Radiotherapy (LRT): A case report  Beatriz E. Amendola, Naipy C. Perez,
Radiotherapeutic Management of Non–Small Cell Lung Cancer in the Minimal Resource Setting  Danielle Rodin, MD, Surbhi Grover, MD, MPH, Melody J. Xu, MD,
European Urology Oncology
Intensity-Modulated Radiotherapy After Extrapleural Pneumonectomy in the Combined- Modality Treatment of Malignant Pleural Mesothelioma  Alexander Chi,
A Multi-Institutional Dosimetric Evaluation of Proton Versus Photon Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma F. Khan, B. Nguyen,
Image–Guided Radiation Therapy for Non–small Cell Lung Cancer
Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer  Nancy El-Bared, MD,
Cone beam computed tomography-based monitoring and management of target and organ motion during external beam radiotherapy in cervical cancer  Nina Boje.
Technical Advances of Radiation Therapy for Thymic Malignancies
Figure 3 Target volume definitions
GHG meeting at ESTRO36 May, 2017
Planning techniques of proton boost
Imaging studies in patients attaining objective response on phase I study. Imaging studies in patients attaining objective response on phase I study. A,
Presentation transcript:

Image-Guided Adaptive Therapy for the Treatment of Lung Cancer C Ramsey, S Mahan, D Chase Thompson Cancer Survival Center, Knoxville,TN

Adaptive IGRT for Lung The first Lung Cancer patient was treated with Helical Tomotherapy at the Thompson Cancer Center in July 2003 7 lung cancer patients have been treated for a total of 199 fractions Each patient had CT imaging prior to treatment delivery Lung Window Bone Window

TCSC-RT 0301: Lung Tomo Protocol Prescription Initial: 44 Gy (2.0 Gy/fraction) Boost: 20 Gy (2.5 Gy/fraction) Margins Initial: GTV + 2-cm Boost: GTV + 1-cm (with DIBH) Plan Optimization Parameters: Pitch: 0.333 Thickness: 2.5 Modulation: 2.5 The total lung volume (right and left lung minus the gross tumor volume) receiving greater than 20 Gy must be 35% or less

Lung Adaptive Therapy Tumor Response TomoImage Fraction #1 5 10 15 20 25 30 40 50 60 70 Elapsed Days Volume (cc) Patient #1 Patient #2 Patient #3 GTV TomoImage Fraction #30 Tumor Response During the course of the therapy (with or without concurrent chemotherapy), the GTV can reduce in volume by a factor of 3 As the GTV shrinks, the target is effectively being treated with an increasing margin GTV

Lung Adaptive Therapy Original Treatment Plan The PTV is reduced every five fractions based on GTV volume reduction in the previous five TomoImages The GTV is reduced in the planning CT image to match each weeks measured tumor volume The GTV is still expanded into the PTV (i.e. margins are the same) Adaptive therapy’s impact increases the larger the original GTV volume and the greater the tumor response Adaptive Composite Plan

Lung Adaptive Therapy PTV Ips. Lung 5 10 15 20 25 30 40 50 60 70 Elapsed Days Volume (cc) Patient #1 Patient #2 Patient #3 Ips. Lung Lung mass reduced to 36% of the original tumor volume Non-Adaptive Weekly Adaptive

Lung Adaptive Therapy PTV 5 10 15 20 25 30 40 50 60 70 Elapsed Days Volume (cc) Patient #1 Patient #2 Patient #3 Lung mass reduced to 25% of the original tumor volume Ips. Lung Non-Adaptive Weekly Adaptive

Lung Adaptive Therapy PTV Ips. Lung 5 10 15 20 25 30 40 50 60 70 Elapsed Days Volume (cc) Patient #1 Patient #2 Patient #3 PTV Ips. Lung Lung mass reduced to 81% of the original tumor volume Weekly Adaptive Non-Adaptive

Adaptive IGRT for Lung Based on the results of this feasibility study, adaptive therapy at a minimum has the potential to decrease radiation induced damage to healthy lung tissue The level of improvement increases with larger initial CTV’s and with increased volume reduction during treatment The potential pitfall of this type of adaptive therapy is the potential for underdosing microscopic extension As the visible GTV decreases, the assumption is that the microscopic extension is also shrinking at the same rate However, margin is still added around the GTV in adaptive therapy, and the final PTV is typically the same size or larger than the initial CTV